We are live on ! Find out more
PG

Prostatis Group Portfolio holdings

AUM $391M
1-Year Est. Return 20.37%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+20.37%
3 Year Est. Return
+56.13%
5 Year Est. Return
+74.88%
10 Year Est. Return
AUM
$164M
AUM Growth
+$77.1M
Cap. Flow
+$71.4M
Cap. Flow %
43.55%
Top 10 Hldgs %
45.49%
Holding
112
New
48
Increased
28
Reduced
19
Closed
15
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
26
SPDR Gold Trust
GLD
$130B
$1.97M 1.2%
11,624
+4,841
+71% +$780K
BLV icon
27
Vanguard Long-Term Bond ETF
BLV
$5.85B
$1.94M 1.19%
26,842
-74
-0.3% -$5.36K
AMGN icon
28
Amgen
AMGN
$198B
$1.61M 0.98%
6,131
+331
+6% +$88.7K
HYG icon
29
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$1.57M 0.96%
21,304
-730
-3% -$53.8K
TMO icon
30
Thermo Fisher Scientific
TMO
$198B
$1.56M 0.95%
2,826
-1,278
-31% -$677K
CVX icon
31
Chevron
CVX
$373B
$1.42M 0.87%
+7,902
New +$1.38M
TDSE
32
DELISTED
Cabana Target Drawdown 16 ETF
TDSE
$1.41M 0.86%
+64,962
New +$1.47M
MSFT icon
33
Microsoft
MSFT
$2.93T
$1.31M 0.8%
5,470
-4,435
-45% -$1.06M
HYLS icon
34
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
$1.19M 0.73%
30,686
-7,826
-20% -$308K
XOM icon
35
ExxonMobil
XOM
$611B
$1.18M 0.72%
10,685
+7,088
+197% +$759K
AAPL icon
36
Apple
AAPL
$4.9T
$1.16M 0.71%
8,952
-6,643
-43% -$949K
KO icon
37
Coca-Cola
KO
$351B
$1.13M 0.69%
+17,832
New +$1.08M
SPGP icon
38
Invesco S&P 500 GARP ETF
SPGP
$2.19B
$1.13M 0.69%
13,647
-63,659
-82% -$5.24M
JPM icon
39
JPMorgan Chase
JPM
$907B
$1.07M 0.65%
7,972
+5,775
+263% +$732K
JNJ icon
40
Johnson & Johnson
JNJ
$609B
$1.05M 0.64%
5,943
+4,250
+251% +$734K
IBM icon
41
IBM
IBM
$200B
$1.05M 0.64%
+7,451
New +$1.03M
JEPI icon
42
JPMorgan Equity Premium Income ETF
JEPI
$45B
$1.05M 0.64%
19,208
+3,200
+20% +$174K
IVV icon
43
iShares Core S&P 500 ETF
IVV
$881B
$1.02M 0.62%
2,643
-158
-6% -$61K
RSPT icon
44
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.38B
$939K 0.57%
+38,640
New +$944K
MRK icon
45
Merck
MRK
$315B
$915K 0.56%
8,245
+5,758
+232% +$589K
TRV icon
46
Travelers Companies
TRV
$78.5B
$839K 0.51%
+4,476
New +$805K
FTCS icon
47
First Trust Capital Strength ETF
FTCS
$7.88B
$838K 0.51%
11,175
-30,738
-73% -$2.27M
VOO icon
48
Vanguard S&P 500 ETF
VOO
$974B
$833K 0.51%
2,370
-560
-19% -$198K
VWOB icon
49
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.21B
$793K 0.48%
13,005
-620
-5% -$37K
VTIP icon
50
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$778K 0.47%
16,658
+260
+2% +$12.4K

Similar funds

Prostatis Group's Q4 2022 Portfolio in Review

As of Q4 2022, Prostatis Group held 112 positions worth $164M, up 89% from $86.8M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Prostatis Group deployed $71.4M of net new capital in Q4 2022, opening 48 new positions and adding to 28 existing holdings. Its largest new stake was Vanguard Value ETF: 120,222 shares worth $16.9M.

By sector, the portfolio is most concentrated in Healthcare at 3.6% of assets, down from 6% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Invesco S&P 500 GARP ETF, an estimated $5.24M trimmed.

  • Prostatis Group's largest Q4 2022 buy was Vanguard Value ETF: 120,222 shares worth $16.9M.
  • Prostatis Group added most to State Street Health Care Select Sector SPDR ETF in Q4 2022, an estimated $2.47M increase.
  • Prostatis Group's biggest Q4 2022 reduction was Invesco S&P 500 GARP ETF, cutting an estimated $5.24M.
  • Prostatis Group fully exited Invesco S&P MidCap Momentum ETF in Q4 2022, selling an estimated $4.01M.
  • Prostatis Group's ten largest holdings make up 45% of its $164M portfolio in Q4 2022.
  • Prostatis Group opened 48 new positions and closed 15 in Q4 2022.
  • Prostatis Group's portfolio value rose 89% quarter-over-quarter to $164M.

Based on Prostatis Group's 13F filing for Q4 2022, filed 23 Mar 2023.